Part of Thermo Fisher Scientific

Anti-BAI1 Polyclonal Antibody

Synonyms:
FLJ41988, GDAIF
Entrez Gene ID:
(Human) 575
UniProt ID:
O14514
Details
Host / Isotype: Rabbit / IgG
Class: Polyclonal
Type: Antibody
Species Reactivity: Human (Hu)
Immunogen: Synthetic peptide, KLH conjugated, corresponding to a C-terminal region of human BAI1 surrounding residue 1200.
Ordering Information
Pierce Anti-BAI1 Polyclonal Antibody
Product Number Pkg. Size Price Purchase
PA1-24590 25 µg $396.00


Storage: -80º C, Avoid Freeze/Thaw Cycles
Form: 25 µg of Peptide affinity purified (1 mg/ml) antibody in PBS, pH 7.7, containing 0.01% sodium azide


Applications Dilution
Immunohistochemistry (IHC) Assay dependent
Product Specific Information
PA1-24590 detects BAI1 in human samples.

PA1-24590 has been successfully used in immunohistochemistry procedures.

PA1-24590 immunogen is a synthetic peptide, KLH conjugated, corresponding to a C-terminal region of human BAI1 surrounding residue 1200.
General Information
BAI1 is an Orphan-B GPCR with an unknown ligand. BAI1 is postulated to be a member of the secretin receptor family, an inhibitor of angiogenesis, and a growth suppressor of glioblastoma. Along with BAI1, there are two other brain-specific angiogenesis inhibitor genes, designated BAI2 and BAI3, which have similar tissue specificities and structures. However, only BAI1 is transcriptionally regulated by p53. Loss of BAI1 expression has been implicated in glioblastoma. BAI1 expression has been reported primarily in brain, but it is also found in colon, lung, esophagus, and uterus. ESTs have been isolated from brain, lung, and placenta libraries.
(This product is for In Vitro experimental use only.)


Learn more about other Thermo Scientific Life Science Research Products
Protein Research Products Cell Culture High Content Screening
Nucleic Acid Technologies PCR Reagents & Plastics RNAi Technologies European Sales

© 2010 Thermo Fisher Scientific Inc.

PO Box 117, Rockford, IL 61105 USA
1-800-874-3723 or 815-968-0747

Trademarks Privacy Statement